How Semaglutide Helps in Cardiovascular Risk Reduction
Introduction Cardiovascular disease (CVD) remains one of the leading causes of mortality worldwide, underscoring the need for effective prevention and treatment strategies. Cardiovascular risk reduction plays a critical role in improving overall health and longevity, particularly for individuals with predisposing conditions like obesity, diabetes, and hypertension. Semaglutide, a ground-breaking medication originally approved for Type 2…